Samara M., Papathanassiou M., Farmakioti I., Anagnostou M., Satra M., Mitrakas L., Anastasiou D., Chasiotis G., Christopoulos A., Anagnostou A., Christodoulou A., Daponte A., Ioannou M., Koukoulis G., Tzortzis V., Vlachostergios P.J. (2021)
The renin-angiotensin system (RAS), besides being a major regulator of blood pressure, is also involved in tumor angiogenesis. Emerging evidence suggests a correlation between the use of pharmacologic RAS inhibitors and a ...